The safety of concomitant transcatheter aortic valve replacement and percutaneous coronary intervention: A systematic review and meta-analysis

BACKGROUND: TAVR is a rapidly spreading treatment option for severe aortic valve stenosis. Significant coronary artery disease (CAD) is present in 40% to 75% of patients undergoing TAVR. However, when to treat the concomitant coronary artery lesions is controversial. METHODS: This is a systematic re...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yong, Huang, Fang-Yang, Huang, Bao-Tao, Xiong, Tian-Yuan, Pu, Xiao-Bo, Chen, Shi-Jian, Chen, Mao, Feng, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728783/
https://www.ncbi.nlm.nih.gov/pubmed/29310382
http://dx.doi.org/10.1097/MD.0000000000008919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728783/
https://www.ncbi.nlm.nih.gov/pubmed/29310382
http://dx.doi.org/10.1097/MD.0000000000008919

Ejemplares similares